You can:
Name | Somatostatin receptor type 1 |
---|---|
Species | Homo sapiens (Human) |
Gene | SSTR1 |
Synonym | SRIF-2 SS-1-R SS1-R SS1R SST1 receptor |
Disease | Alzheimer disease Cushing's disease Neuroendocrine cancer |
Length | 391 |
Amino acid sequence | MFPNGTASSPSSSPSPSPGSCGEGGGSRGPGAGAADGMEEPGRNASQNGTLSEGQGSAILISFIYSVVCLVGLCGNSMVIYVILRYAKMKTATNIYILNLAIADELLMLSVPFLVTSTLLRHWPFGALLCRLVLSVDAVNMFTSIYCLTVLSVDRYVAVVHPIKAARYRRPTVAKVVNLGVWVLSLLVILPIVVFSRTAANSDGTVACNMLMPEPAQRWLVGFVLYTFLMGFLLPVGAICLCYVLIIAKMRMVALKAGWQQRKRSERKITLMVMMVVMVFVICWMPFYVVQLVNVFAEQDDATVSQLSVILGYANSCANPILYGFLSDNFKRSFQRILCLSWMDNAAEEPVDYYATALKSRAYSVEDFQPENLESGGVFRNGTCTSRITTL |
UniProt | P30872 |
Protein Data Bank | N/A |
GPCR-HGmod model | P30872 |
3D structure model | This predicted structure model is from GPCR-EXP P30872. |
BioLiP | N/A |
Therapeutic Target Database | T16633 |
ChEMBL | CHEMBL1917 |
IUPHAR | 355 |
DrugBank | BE0000452 |
Name | BDBM144778 |
---|---|
Molecular formula | C95H123N19O10S2 |
IUPAC name | 1-[3-[(2S,5S,8S,11R,14S,17S,20S,27R)-14-(4-aminobutyl)-5-benzyl-27-[bis[2-[[(6aR,9R,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]methylsulfanyl]ethyl]amino]-17-[(1R)-1-hydroxyethyl]-20-[(4-hydroxyphenyl)methyl]-11-(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,28-octaoxo-8-(pyridin-4-ylmethyl)-1,4,7,10,13,16,19,22-octazacyclooctacos-2-yl]propyl]guanidine |
Molecular weight | 1755.27 |
Hydrogen bond acceptor | 18 |
Hydrogen bond donor | 17 |
XlogP | 8.8 |
Synonyms | US8952128, 35 |
Inchi Key | BYXGHJZXSWDEAC-KUFJZVQMSA-N |
Inchi ID | InChI=1S/C95H123N19O10S2/c1-57(115)86-94(124)110-77(45-59-27-29-66(116)30-28-59)87(117)100-34-12-10-26-81(114(38-40-125-55-61-42-70-68-19-13-23-73-84(68)64(51-103-73)48-82(70)112(2)53-61)39-41-126-56-62-43-71-69-20-14-24-74-85(69)65(52-104-74)49-83(71)113(3)54-62)93(123)106-76(25-15-35-101-95(97)98)88(118)107-78(44-58-16-5-4-6-17-58)90(120)108-79(46-60-31-36-99-37-32-60)91(121)109-80(47-63-50-102-72-21-8-7-18-67(63)72)92(122)105-75(89(119)111-86)22-9-11-33-96/h4-8,13-14,16-21,23-24,27-32,36-37,50-52,57,61-62,70-71,75-83,86,102-104,115-116H,9-12,15,22,25-26,33-35,38-49,53-56,96H2,1-3H3,(H,100,117)(H,105,122)(H,106,123)(H,107,118)(H,108,120)(H,109,121)(H,110,124)(H,111,119)(H4,97,98,101)/t57-,61-,62-,70-,71-,75+,76+,77+,78+,79+,80-,81-,82-,83-,86+/m1/s1 |
PubChem CID | 91809312 |
ChEMBL | N/A |
IUPHAR | N/A |
BindingDB | 144778 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. This ligand has a partition coefficient log P greater than 5. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 99.7 nM | N/A | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417